Fracture Incidence Reduction And Safety Of TSE-424 (Bazedoxifene Acetate) Compared To Placebo And Raloxifene In Osteoporotic Postmenopausal Women
Fracture Incidence Reduction And Safety Of TSE-424 (Bazedoxifene Acetate) Compared To Placebo And Raloxifene In Osteoporotic Postmenopausal Women
The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.
Inclusion Criteria:
Exclusion Criteria:
Cadwell, Idaho 83605, United States
Lousiville, Kentucky 40291, United States
Kalamazaoo, Michigan 49048, United States
Manchester Twp, New Jersey 08759, United States
Mayfield Village, Ohio 44143, United States
Langhome, Pennsylvania 19047, United States
Waterdown, South Dakota 57201, United States
Provincia de Buenos Aires, Argentina
Schiepsebos, 6, Belgium
Duque de Caxias - Cuiaba, Mato Grosso 78043-306, Brazil
PRC, Hong Kong
Sai Ying Pung, Hong Kong
H-6720 Szeged, Hungary
Seccion de Lomas Verdes, State of Mexico CP 53120, Mexico
Bucharesti, 7000, Romania